2012
DOI: 10.1007/s00403-012-1232-6
|View full text |Cite
|
Sign up to set email alerts
|

A reconstructed human epidermal keratinization culture model to characterize ceramide metabolism in the stratum corneum

Abstract: To examine factors that regulate ceramide production during keratinization of the human stratum corneum (SC), we developed a reconstructed human epidermal keratinization model in which a fresh layer of SC is newly formed within 1 week. Addition of the UDP-glucose: ceramide glucosyltransferase inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol significantly diminished SC ceramide levels (expressed as µg/mg protein) with decreased glucosylceramide levels. Desipramine hydrochloride, an inhibitor of sphing… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
19
0

Year Published

2012
2012
2016
2016

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 33 publications
0
19
0
Order By: Relevance
“…The most striking discrepancy occurs for the expression of aSMase following treatment with IL-4 where the protein and the enzymatic activity levels are significantly up-regulated despite the fact that aSMase gene expression is significantly down-regulated by IL-4. Although the discrepancy between the gene expression and the protein/ activity levels for the mechanism(s) involved in the downregulation of ceramide/protein level in the SC by IL-4 remains to be clarified, the reason why the distinctly increased levels of protein and enzymatic activity does not necessarily contribute to the increase in ceramide levels in the SC seems to be as follows: The inhibition or down-regulation of ceramide synthetic enzymes, such as SMase and BGDase, directly results in the diminished level of ceramides in the SC, leaving sphingomyelin and glucosylceramide as reaction residues in the SC, as seen in Niemann-Pick disease [31] and in Gaucher disease [32], respectively, or an in vivo inhibition study using a BGDase inhibitor [33] and in our study using human epidermal equivalents [23]. The stimulation of those activities does not necessarily reflect the increased level of ceramides in the SC because those enzyme activities occur at levels sufficient to completely degrade sphingomyelin and glucosylceramide without leaving their residues in the SC under the normal physiological conditions of keratinization.…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…The most striking discrepancy occurs for the expression of aSMase following treatment with IL-4 where the protein and the enzymatic activity levels are significantly up-regulated despite the fact that aSMase gene expression is significantly down-regulated by IL-4. Although the discrepancy between the gene expression and the protein/ activity levels for the mechanism(s) involved in the downregulation of ceramide/protein level in the SC by IL-4 remains to be clarified, the reason why the distinctly increased levels of protein and enzymatic activity does not necessarily contribute to the increase in ceramide levels in the SC seems to be as follows: The inhibition or down-regulation of ceramide synthetic enzymes, such as SMase and BGDase, directly results in the diminished level of ceramides in the SC, leaving sphingomyelin and glucosylceramide as reaction residues in the SC, as seen in Niemann-Pick disease [31] and in Gaucher disease [32], respectively, or an in vivo inhibition study using a BGDase inhibitor [33] and in our study using human epidermal equivalents [23]. The stimulation of those activities does not necessarily reflect the increased level of ceramides in the SC because those enzyme activities occur at levels sufficient to completely degrade sphingomyelin and glucosylceramide without leaving their residues in the SC under the normal physiological conditions of keratinization.…”
Section: Discussionmentioning
confidence: 97%
“…Comparison of the lipid composition by thin layer chromatography (TLC) shows that the pattern of lipids obtained from the whole SC layers of the 3-dimensional epidermal model is almost identical to that from the 3 SC layers of normal human forearm skin [23], indicating the suitability of the 3-dimensional epidermal model. Our recent study using inhibitors of ceramide-producing enzymes in the same epidermal model indicated that the major metabolic pathways leading to ceramide synthesis through the interface between the SC and the granular layer occur in the 3-dimensional epidermal models in a pattern similar to that seen in vivo [23]. Here we report that the Th2-type of inflammation evoked in AD skin is one of the essential factors in down-regulating the level of ceramides in the SC.…”
mentioning
confidence: 88%
See 1 more Smart Citation
“…31 The epidermis, especially the stratified squamous layer, is producing and metabolizing Cer actively. 32 In those tissues where keratinization occurs (such as stratum corneum), Cer form massive intra-and extracellular lamellar membranes and bodies that, together with keratin, FC, and free fatty acids, create a water-permeability barrier. It seems plausible that the excessive amounts of Cer overproduced by abnormal epithelial cells could mix with normal meibomian gland secretions and change its lipid balance in the process that can be exacerbated by the diminishing capacity of acinar cells to produce normal lipids.…”
Section: Discussionmentioning
confidence: 99%
“…In the conversion of lamellar granule-associated acylglucosylceramides to covalently bound ω-hydroxyceramides on the outer surface of the cornified envelope, 3 types of enzymes have been implicated - glucocerebrosidase [71,72,73], lipoxygenases [43] and transglutaminase [44]. How are the actions of these enzymes coordinated and regulated?…”
Section: Future Directionsmentioning
confidence: 99%